World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
112
Citations
52720
World Ranking
5106
National Ranking
159

Overview

Fabio Ciceri is affiliated with Vita-Salute San Raffaele University in Italy and has contributed extensively to the field of medicine with a focus on hematology and related disciplines. Their work spans a broad range of topics including hematopoietic stem cell transplantation, acute leukemia research, infectious diseases, oncology, and immunology.

The primary fields of study covered by their publications include:

  • Medicine

Within this broad field, Ciceri's research delves into several subfields:

  • Hematology
  • Infectious Diseases
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Immunology

Key research topics addressed in their work are:

  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • CAR-T Cell Therapy Research
  • Chronic Myeloid Leukemia Treatments

Fabio Ciceri has frequently published in several scientific venues, including:

  • Blood
  • Bone Marrow Transplantation
  • Transplantation and Cellular Therapy
  • HemaSphere
  • Frontiers in Oncology

Among their recent papers, notable examples are:

  • "Autoantibodies against type I IFNs in patients with life-threatening COVID-19" (2020, Science)
  • "Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors" (2020, Brain Behavior and Immunity)
  • "Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study" (2020, The Lancet Rheumatology)
  • "Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths" (2021, Science Immunology)
  • "Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up" (2021, Brain Behavior and Immunity)

Collaborations are a significant part of Ciceri's research endeavors. Frequent co-authors include:

  • Mohamad Mohty
  • Arnon Nagler
  • Myriam Labopin
  • Didier Blaise
  • Annalisa Ruggeri

Best Publications

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

    Paul Bastard;Paul Bastard;Paul Bastard;Lindsey B. Rosen;Qian Zhang;Eleftherios Michailidis

  • Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors.

    Mario Gennaro Mazza;Rebecca De Lorenzo;Caterina Conte;Sara Poletti

  • Retinoic acid and arsenic trioxide for acute promyelocytic leukemia

    F. Lo-Coco;G. Avvisati;M. Vignetti;C. Thiede

  • Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.

    Alessandra Biffi;Eugenio Montini;Laura Lorioli;Martina Cesani

  • Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells

    Margherita Norelli;Barbara Camisa;Giulia Barbiera;Laura Falcone

  • Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome

    Alessandro Aiuti;Luca Biasco;Samantha Scaramuzza;Francesca Ferrua

  • Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency

    Alessandro Aiuti;Federica Cattaneo;Stefania Galimberti;Ulrike Benninghoff

  • Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.

    Giulio Cavalli;Giacomo De Luca;Corrado Campochiaro;Emanuel Della-Torre

  • Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML

    Alexander E. Perl;Giovanni Martinelli;Jorge E. Cortes;Andreas Neubauer

  • IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors

    Nicoletta Cieri;Barbara Camisa;Fabienne Cocchiarella;Mattia Forcato

  • Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation

    Luca Vago;Serena Kimi Perna;Monica Zanussi;Benedetta Mazzi

  • Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer

    Elena Provasi;Pietro Genovese;Angelo Lombardo;Zulma Magnani

  • Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

    Olaf Penack;Monia Marchetti;Tapani Ruutu;Mahmoud Aljurf

  • Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis

    Fabio Ciceri;Luigi Beretta;Anna Mara Scandroglio;Sergio Colombo

  • Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

    Renato Bassan;Orietta Spinelli;Elena Oldani;Tamara Intermesoli

  • Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial

    Maria Sessa;Laura Lorioli;Francesca Fumagalli;Serena Acquati

  • Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up.

    Mario Gennaro Mazza;Mariagrazia Palladini;Rebecca De Lorenzo;Cristiano Magnaghi

  • Complement as a target in COVID-19?

    Antonio M. Risitano;Dimitrios C. Mastellos;Markus Huber-Lang;Despina Yancopoulou

  • Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

    Fabio Ciceri;Chiara Bonini;Maria Teresa Lupo Stanghellini;Attilio Bondanza

  • A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation

    Fabio Ciceri;Myriam Labopin;Franco Aversa;Jakob M. Rowe

Frequent Co-Authors

Chiara Bonini
Chiara Bonini Vita-Salute San Raffaele University
Arnon Nagler
Arnon Nagler Sheba Medical Center
Claudio Bordignon
Claudio Bordignon MolMed (Italy)
Myriam Labopin
Myriam Labopin Université Paris Cité
Luca Vago
Luca Vago Vita-Salute San Raffaele University
Alessandro Rambaldi
Alessandro Rambaldi University of Milan
Bipin N. Savani
Bipin N. Savani Vanderbilt University Medical Center
Paolo Corradini
Paolo Corradini University of Milan
Alessandro Aiuti
Alessandro Aiuti Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine opens the door to many related fields you can enter through online study, offering flexibility and diverse opportunities. Those eager to advance their nursing careers quickly may consider an accelerated lpn program, which allows you to qualify as a Licensed Practical Nurse in less time than traditional pathways.

For nurses seeking higher credentials, the cheapest dnp program can help you achieve a Doctor of Nursing Practice degree without a huge financial burden. If you're interested in mental health, there are also shortest post master's pmhnp online programs designed to quickly train specialists in psychiatric mental health.

Beyond clinical roles, a health care administration degree online can prepare you for leadership positions in hospitals, clinics, or public health organizations. No matter your background or career goals, these online options offer affordable and accelerated pathways to thrive in the healthcare sector.

Best Scientists Citing Fabio Ciceri

Trending Scientists

Recently Published Articles